PRESS-RELEASE ·Filed May 4, 2026
Press release · Contract
Actionable Insight • Neutral
Monitor for definitive agreement and commercial launch timeline. No near-term catalyst; partnership progress is incremental and non-material without revenue terms.
Final — all horizons settled through T+60d
CBUS ▲ +30.20% at T+60d
NEUTRAL call +30.20% · α vs SPY +28.34% · entry $1.49 → $1.94
T+1d
+3.36%
call +3.36% · α +2.56%
$1.54
settled 6mo ago
T+5d
-7.38%
call -7.38% · α -10.32%
$1.38
settled 6mo ago
T+20d
-1.34%
call -1.34% · α -6.99%
$1.47
settled 5mo ago
T+60d
+30.20%
call +30.20% · α +28.34%
$1.94
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Cibus announced transfer of gene-edited herbicide-tolerant rice materials to partner Interoc for testing and production in Latin America. This is a non-financial pipeline progress milestone with no disclosed commercial terms or near-term revenue impact.
Key Facts
- Cibus transferred gene-edited rice materials to Interoc for herbicide tolerance trait.
- Interoc to begin testing and production for Latin American commercial launch.
- No definitive licensing agreement or financial terms disclosed.
- Milestone achieved on schedule; additional trait materials expected over next year.
Financial Impact
No financial figures disclosed; potential future royalties not quantified.
Risk Factors
- Cibus needs additional near-term funding to finance activities; capital markets risk.
- No definitive license agreement yet; negotiations may fail.
- Regulatory frameworks for gene editing may change, impacting commercialization.
Market Snapshot
Exchange
Nasdaq
Sector
Agricultural Chemicals
Analyst Consensus
78% bullish (9 analysts)
Investment Themes
Materials & Mining
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3286548 |
12 reports for CBUS
100% Hit rate @ T+20 Went positive at some point 3 of 3 best @ T+60▲ +54.87%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 28, 2026 28d ago | Press Release | $1.55 | awaiting T+20 | — | $1.39 (−10.00%) |
Jun 11, 2026 19w ago | Institutional Cluster | $1.25 $1.90 | ▲ +52.00% | ▲ +50.11% | $1.39 (+11.60%) |
Jun 9, 2026 19w ago | 8-K | $1.23 $1.50 | ▲ +21.95% | ▲ +20.50% | $1.39 (+13.41%) |
Jun 8, 2026 20w ago | Press Release | $1.23 $1.50 | ▲ +21.95% | ▲ +20.50% | $1.39 (+13.41%) |
May 26, 2026 21w ago | EFFECT | $1.43 $1.38 | ▲ +3.50% | ▲ +1.55% | $1.39 (+2.45%) |
May 14, 2026 23w ago | 8-K | $1.31 $1.27 | ▼ −3.05% | ▼ −5.17% | $1.39 (+6.49%) |
May 4, 2026 25w ago | Press Release | $1.49 $1.47 | ▼ −1.34% | ▼ −6.99% | $1.39 (−6.38%) |
Apr 20, 2026 27w ago | DEFA14A | $1.49 $1.28 | ▼ −14.09% | ▼ −19.01% | $1.39 (−6.38%) |
Mar 26, 2026 30w ago | 424B5 | $1.88 $1.49 | ▲ +20.74% | ▲ +33.49% | $1.39 (+25.80%) |
Mar 26, 2026 30w ago | Press Release | $2.13 $1.50 | ▼ −29.58% | ▼ −40.24% | $1.39 (−34.51%) |
Showing 10 of 12
US Market Status
Market Closed — Opens Wed (10h 55m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers